Page last updated: 2024-12-06
azuletil
Description
azuletil: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
egualen : A member of the class of azulenes carrying sulfo, ethyl and isopropyl substituents at positions 1, 3 and 7 respectively. Used (in the form of its sodium salt) for treatment of gastric ulcers. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 65858 |
CHEMBL ID | 2105570 |
CHEBI ID | 85542 |
SCHEMBL ID | 668397 |
MeSH ID | M0171654 |
Synonyms (23)
Synonym |
azuletil |
3-ethyl-7-propan-2-ylazulene-1-sulfonic acid |
egualeno [inn-spanish] |
99287-30-6 |
egualeno |
egualenum |
17vm9wn49u , |
egualen |
egualene |
egualen [inn] |
egualene [inn-french] |
egualenum [inn-latin] |
3-ethyl-7-isopropyl-1-azulenesulfonic acid |
unii-17vm9wn49u |
chebi:85542 , |
CHEMBL2105570 |
egualen [who-dd] |
SCHEMBL668397 |
DTXSID2052861 |
3-ethyl-7-isopropylazulene-1-sulfonic acid |
3-ethyl-7-(propan-2-yl)azulene-1-sulfonic acid |
Q27158630 |
1-azulenesulfonic acid, 3-ethyl-7-(1-methylethyl)- |
Roles (2)
Role | Description |
anti-ulcer drug | One of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. |
thromboxane A2 antagonist | An antagonist that binds to and deactivates thromboxane A2 receptors. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (2)
Class | Description |
arenesulfonic acid | Organic derivatives of sulfonic acid in which the sulfo group is linked directly to carbon of an aryl group. |
azulenes | Any carbobicyclic compound whose skeleton consists of a cyclopentane ring ortho-fused to a cycloheptane ring. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 6 (85.71) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 13.01
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 13.01 (24.57) | Research Supply Index | 2.08 (2.92) | Research Growth Index | 5.09 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |